@njama
« n 1999, after launching its first campaign against Haemophilus influenzae type B (Hib) and paying $3 per imported vaccine dose, Cuba began researching a possible alternative to the expensive vaccine. With more than 500,000 children dying annually from Hib and vaccines costly and complex to produce, Cuba took up the call. Four years later, with collaboration from researchers from the University of Ottawa, Cuba became the first country in the world to successfully produce a synthetic vaccine for the virus. After extensive clinical trials conducted with the Canadians, the Cuban vaccine showed a 99.7% success rate. In 2004 it was introduced into the national vaccination campaign, and in 2005 Cuba won its sixth WIPO Gold Medal. »
$3 per imported vaccine dose = ce qui fait beaucoup pour cuba.